Co-Investigator(Kenkyū-buntansha) |
内藤 幹彦 東京大学, 大学院薬学系研究科(薬学部), 特任教授 (00198011)
村田 茂穂 東京大学, 大学院薬学系研究科(薬学部), 教授 (20344070)
岩井 一宏 京都大学, 医学研究科, 教授 (60252459)
深井 周也 東京大学, 定量生命科学研究所, 委嘱教授 (10361792)
出水 庸介 国立医薬品食品衛生研究所, 有機化学部, 部長 (90389180)
岡本 晃充 東京大学, 先端科学技術研究センター, 教授 (60314233)
|
Budget Amount *help |
¥229,320,000 (Direct Cost: ¥176,400,000、Indirect Cost: ¥52,920,000)
Fiscal Year 2022: ¥9,620,000 (Direct Cost: ¥7,400,000、Indirect Cost: ¥2,220,000)
Fiscal Year 2021: ¥9,620,000 (Direct Cost: ¥7,400,000、Indirect Cost: ¥2,220,000)
Fiscal Year 2020: ¥14,430,000 (Direct Cost: ¥11,100,000、Indirect Cost: ¥3,330,000)
Fiscal Year 2019: ¥14,430,000 (Direct Cost: ¥11,100,000、Indirect Cost: ¥3,330,000)
Fiscal Year 2018: ¥181,220,000 (Direct Cost: ¥139,400,000、Indirect Cost: ¥41,820,000)
|
Outline of Final Research Achievements |
In this research project, we have promoted the next-generation ubiquitin research through intensive collaborations between life scientists and chemists to develop ubiquitin chemo-technologies with the aim of elucidating the molecular principle of various ubiquitin-mediated cellular functions and developing new methods to regulate cellular functions by manipulating ubiquitylation. This research management group aims to facilitate close collaborations and encourage young researchers. For this, we organized annual meetings and domestic and international symposiums and built research platforms. We also supported short-term overseas study abroad and held young researcher workshops. In addition, we have made a website and distributed newsletters to make our research activities widely known.
|